Data Analytics

Data analytics hiring levels in the pharma industry fell to a year-low in August

The proportion of pharmaceutical companies hiring for cloud related positions rose to a year-high in August 2021, with 42.7% of the companies included in our analysis recruiting for at least one such position.

The latest figure was lower than the 69.8% of companies who were hiring for data analytics-related jobs a year ago.

Powered by 

The proportion of pharmaceutical companies hiring for data analytics related positions dropped in August 2022 compared with the equivalent month last year, with 62.9% of the companies included in our analysis recruiting for at least one such position. 

This latest figure was lower than the 69.8% of companies who were hiring for data analytics-related jobs a year ago and a decrease compared to the figure of 69.3% in July 2022.

When it came to the rate of all job openings that were linked to data analytics, related job postings rose in August 2022 from July 2022, with 13.7% of newly posted job advertisements being linked to the topic. 

This latest figure was an increase compared to the 10.8% of newly advertised jobs that were linked to data analytics in the equivalent month a year ago. 

Data analytics is one of the topics that GlobalData, from whom our data for this article is taken, have identified as being a key disruptive force facing companies in the coming years. Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges.

Our analysis of the data shows that pharmaceutical companies are currently hiring for data analytics jobs at a rate higher than the average for all companies within GlobalData's job analytics database. The average among all companies stood at 5.5% in August 2022. 

GlobalData's job analytics database tracks the daily hiring patterns of thousands of companies across the world, drawing in jobs as they're posted and tagging them with additional layers of data on everything from the seniority of each position to whether a job is linked to wider industry trends.

Go to article: Home | Medicine in outer spaceGo to article: In this issueGo to article: ContentsGo to article: CSafeAPSGo to article: AgilentGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Pfeiffer VacuumGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: Allpack group agGo to article: CommentGo to article: Sandoz spin-off continues Novartis’ focus on innovationGo to article: High risk, high reward – the future of CAR-T therapy in CLLGo to article: bluebird bio bags landmark FDA approvals for gene therapiesGo to article: Covid-19 vaccine companies boosted with over 80% revenue growthGo to article: Urgent need to update Canada’s breast cancer screening guidelinesGo to article: The epidemiology of RSV changed in UK children during the pandemic Go to article: Zenatek Company Insight Go to article: BEA TechnologiesGo to article: In DepthGo to article: Medicine in outer space: drug development, manufacturing, and beyondGo to article: Oncology therapies dominate the orphan drug landscapeGo to article: How environmental factors could influence disease and drugsGo to article: Joining the dots: How gene regulatory network tools are unearthing drugsGo to article: Inflation drives pharma manufacturing focus on sustainability Go to article: What do remote assessments mean for sponsors?Go to article: CMO Moves: Regulatory catalysts for drug manufacturing-OctoberGo to article: TripletreeGo to article: In DataGo to article: Data analytics hiring levels in the pharma industry fell to a year-low in AugustGo to article: Pharma found it easier to fill cloud vacancies in Q2 of 2022Go to article: Pharma filings see a 56% increase in big data mentions since Q2 of 2021Go to article: Industrial automation hiring levels in pharma rose in August 2022Go to article: EventsGo to article: Next issue